India's Missions Fund The Builders. Policy Must Now Support The Anchor Buyers.

India vaccinated a billion people and supplied 99 countries by acting as regulator, customer, and export enabler at once. Viksit Bharat 2047 requires that wartime alignment become peacetime doctrine.

India's industrial policy is levelling up the supply side of its sovereign technology equation. The demand side is the unfinished half. The National Technology Missions now command a combined outlay exceeding ₹3.3 lakh crore (₹3.3 trillion). The ₹1 lakh crore (₹1 trillion) Research, Development and Innovation Scheme is funding private R&D at a scale India has never attempted. A new lattice of trade agreements is reconnecting Indian suppliers to the majority of global GDP. This architecture answers the question of what India builds and who funds the building.

What policy has not yet engineered is who buys what India builds. Without matching demand-side reform, the supply side will mature into capacity without customers. Grant capital without anchor demand is half an industrial policy. India is now close enough to completing the first half that the second half must begin in earnest.
‍

COVID Proved That Indian Policy Can Align Capacity With Demand At Wartime Speed

The pandemic supplied the essential ecidence. When the crisis demanded it, Indian policy fused regulatory clearance, manufacturing scale-up, and state procurement into a single continuum. The results were historic. India administered over 220 crore (2.2 billion) vaccine doses domestically, and sent over 30 crore (300 million) doses to 99 countries and two United Nations organisations under the Vaccine Maitri programme.

The state did this by playing three roles simultaneously. It was the regulator that compressed approval timelines. It was the anchor customer that committed to purchase at national scale, spending over ₹36,000 crore (₹360 billion) on vaccine procurement alone. It was the export enabler that turned domestic capacity into global supply. Subsidy was the smallest part of this story. Indian pharmaceutical manufacturers scaled because demand was guaranteed before the first vial shipped.

The lesson is precise. When the Indian state aligns its purchasing power with the industrial ambition and manufacturing competence of its citizens, Indian industry delivers for the nation and the world at wartime speed. That alignment must now become peacetime doctrine.
‍

Viksit Bharat 2047 Demands Wartime Urgency Today

India is a $4.2 trillion economy entering the most consequential stretch of its development arc. The Viksit Bharat commitment is explicit. India intends to be a developed economy by 2047, which leaves roughly two decades to complete a transition that history suggests is brutally difficult. The World Bank's World Development Report 2024 counts only 34 middle-income economies that have reached high-income status since 1990, and more than a third of those did so through European Union integration or oil discoveries. Neither route is available to India. The remaining 108 middle-income countries sit in the trap, with growth typically stalling at about 10% of US per capita income. India must engineer its escape through productivity, technology, and manufacturing depth, and it must do so on a deadline.

The scoreboard sharpens the urgency. Index agencies that track Asian manufacturing competitiveness consistently rank India below Malaysia and Vietnam, economies a fraction of India's size, demographic depth, and scientific base. From an Indian policy perspective, this is unacceptable. It is a standing indictment that must be answered with the same urgency the country summoned during the pandemic.

A nation that vaccinated a billion people in under two years has already demonstrated its wartime operating mode. The 2047 deadline requires that mode to be switched on permanently rather than reserved for emergencies.
‍

The Missions and the RDI Scheme Are Repairing the Supply Side, and Repairing Trust

The supply-side repair is underway and it is serious. The National Technology Missions span semiconductors, quantum, AI, green hydrogen, biotechnology, and critical minerals. The Anusandhan National Research Foundation is rebuilding the research base with a ₹50,000 crore (₹500 billion) outlay. The RDI Scheme, approved in July 2025 and launched by the Prime Minister in November 2025, places ₹1 lakh crore (₹1 trillion) of long-tenor, low-cost capital behind private sector R&D in sunrise sectors. The SHANTI Act has opened nuclear energy to private capital for the first time since 1962. Taken together, this is the most coherent supply-side industrial architecture India has ever assembled.

The deeper repair is institutional rather than financial. For four decades before 1991, Indian industrial and labour policy treated private enterprise as an adversary to be licensed, rationed, and policed. That adversarial hangover still shapes domestic manufacturing behaviour. It is visible in private underinvestment in capacity, in the reluctance of firms to commit to long-horizon R&D, in a preference for profits over market share, and in a default assumption among entrepreneurs that the state is an obstacle to be managed rather than a partner to be enlisted.

Grant capital therefore does double duty. It funds research, and it rebuilds trust. Every RDI disbursement and mission contract signals that the Indian state now treats private enterprise and innovation as instruments of national capability. The missions are the first leg of a continuum of trust establishment between government and private innovation.
‍

The FTA Architecture Is Re-integrating India with External Demand

External demand is being engineered with real deliberateness. In 2021, Indian exporters enjoyed preferential access to less than 10% of global GDP. By 2026, the share approaches 57%. The UAE and Australia agreements of 2022, the EFTA pact in force since October 2025 with its $100 billion investment commitment, the UK agreement signed in July 2025, and the Oman and New Zealand agreements concluded in December 2025 together cover economies worth over $63 trillion and annual bilateral trade of $615 billion. The India-EU agreement concluded in January 2026 is in legal vetting, with entry into force expected in 2027. The interim framework with the United States, which cuts tariffs and establishes new commitments in stages, is under works.

These agreements should be read as demand-side policy as well. They reset the unit economics of expansion for Indian firms in specialty chemicals, electronics, engineering goods, and pharmaceuticals by guaranteeing the terms on which the world buys Indian. The honest observation is that India has applied this deliberateness to external demand while leaving internal demand, the demand the state itself controls, largely unreformed. The weaker flank will be at home.
‍

PSUs Cannot Remain The Hardest Customers In India For Indian Innovators

The public sector should be the natural anchor customer for India's deep tech and innovation generation. In practice, PSUs remain among the hardest customers in the country for Indian innovators to serve. Tender documents are over-engineered around legacy specifications that exclude new architectures by design. Qualification criteria demand turnover histories and past supply records that no startup can possess. Pilot opportunities are rare, slow, and structured as exceptions rather than as a standing track. Test beds, characterisation facilities, and validation infrastructure built with public money sit behind institutional walls instead of being shared with the private industrial base.

This is the operational residue of the pre-1991 posture. Two generations of Indian enterprise faced the same wall, as the state directed its business to its own enterprises and left private industry competing against the state on an unlevelled field.

The consequence is visible in which industries won. Automobiles, banking, information technology, and pharmaceuticals became India's champions precisely because they catered directly to household demand or went global from day one. They succeeded by never depending on the state as a customer. India's deep tech generation has no such luxury. Semiconductors, defence technology, nuclear components, space tech, and industrial robotics were built in every economy that has them with the state as first buyer. India will be no exception.
‍

The State Is Beginning To Buy - Three Examples Demonstrate The Templates

The encouraging news is that the template is already emerging. In space, IN-SPACe has awarded India's first fully indigenous commercial Earth observation constellation to a consortium led by Indian space technology startups. Twelve satellites and over ₹1,200 crore (₹12 billion) of committed value will be built, owned, and operated by private industry, with the state acting as framework-setter and anchor customer. In defence, the 2026 acquisition reforms have ended Bharat Dynamics' decades-long monopoly over tactical missile production, with DRDO distributing ten to twelve missile programmes across public and private development partners, and firms such as Bharat Forge and ICOMM now building alongside BDL rather than waiting behind it. In energy, the government is structuring assured power purchase agreements and financial incentives for private nuclear developers under the SHANTI Act framework, which is demand engineering rather than subsidy.

Each example pairs supply-side reform with demand-side commitment. The constellation came with a customer. The missile programmes came with orders. The nuclear opening is coming with offtake. That pairing is the model, and it must now be replicated deliberately across the industrial economy rather than left to emerge sector by sector.
‍

Policy Must Codify A Continuum From Grant Capital To Global Champion

The reform task is to stitch these instincts into an unbroken continuum. It begins with grant capital flowing to startups and research labs through the RDI Scheme and ANRF. It runs through universities as research partners and PSUs as pilot customers, where new technology earns its first deployment at meaningful scale. It extends to PSUs and government departments as scale customers, converting validated pilots into multi-year orders. It culminates in PSUs acting as logistics partners and early validators as Indian firms expand abroad, vouching for technology they have already deployed at home.

PSUs must cultivate rainforests of domestic supply capacity across the sunrise sectors the missions are funding, from semiconductors and the energy transition to advanced materials, chemicals, pharmaceuticals, AI, robotics, and industrial automation. Four reforms would convert intent into practice. Standardised pilot procurement tracks should give startups a defined route to first deployment. Test-bed access frameworks should make public validation infrastructure available to private innovators as a matter of right. Tender specifications should be rewritten around outcomes rather than legacy designs. PSU capital expenditure should carry explicit procurement targets for indigenous deep technology, measured and published annually.
‍

Demand Support Must Extend Beyond The PSUs

PSU demand alone cannot absorb the supply side now being built. Targeted demand-side policy must reach across nuclear energy, coal gasification, shipbuilding, defence technology, solar manufacturing, railway and electrical equipment, semiconductors, robotics, AI, and chemicals. The state's toolkit is wider than its enterprises. Advance market commitments can guarantee buyers for technologies before they reach scale. Assured offtake can underwrite first plants. First-buyer mandates across central and state departments can do for deep technology what state procurement did for vaccines.

A manufacturing rank behind smaller Asian economies and the 2047 ambition are incompatible, and the distance between them is demand policy. The supply side is being rebuilt with conviction and capital. India has financed its builders. It must now become their first anchor customer.
‍

A version of this article was published on moneycontrol.com

DISCLAIMER

_{The views expressed herein are those of the author as of the publication date and are subject to change without notice. Neither the author nor any of the entities under the 3one4 Capital Group have any obligation to update the content. This publications are for informational and educational purposes only and should not be construed as providing any advisory service (including financial, regulatory, or legal). It does not constitute an offer to sell or a solicitation to buy any securities or related financial instruments in any jurisdiction. Readers should perform their own due diligence and consult with relevant advisors before taking any decisions. Any reliance on the information herein is at the reader's own risk, and 3one4 Capital Group assumes no liability for any such reliance.Certain information is based on third-party sources believed to be reliable, but neither the author nor 3one4 Capital Group guarantees its accuracy, recency or completeness. There has been no independent verification of such information or the assumptions on which such information is based, unless expressly mentioned otherwise. References to specific companies, securities, or investment strategies are not endorsements. Unauthorized reproduction, distribution, or use of this document, in whole or in part, is prohibited without prior written consent from the author and/or the 3one4 Capital Group.}